COPERNIC CATALYSTS, INC. – Trademark Portfolio
Entity Type: 03
COPERNIC CATALYSTS, INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include COPERNIC. The owner is based in Cambridge, MA.
750 Main Street
Cambridge, MA 02139
Showing of trademarks Trademarks
Trademark Classifications
COPERNIC CATALYSTS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does COPERNIC CATALYSTS, INC. have?
COPERNIC CATALYSTS, INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does COPERNIC CATALYSTS, INC. file in?
COPERNIC CATALYSTS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are COPERNIC CATALYSTS, INC.'s most well-known trademarks?
COPERNIC CATALYSTS, INC.'s registered trademark portfolio includes well-known marks such as COPERNIC. These are among 1 currently registered trademark in the portfolio.
What is COPERNIC CATALYSTS, INC.'s trademark registration success rate?
COPERNIC CATALYSTS, INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.